Beauty care veteran Meri Baregamian, a former executive at Walgreens Boots Alliance, has joined spa and beauty products company Bliss as chief executive officer. Bliss said Baregamian took the reins as CEO effective July 7.
Delhaize Group and Ahold expect to complete their merger by the end of this month. The companies said Tuesday that the closure of the $29 billion merger deal, announced in June 2015, still awaits final approval by the Federal Trade Commission.
Lannett Co. has been cleared by the Food and Drug Administration to market paroxetine extended-release tablets, an antidepressant, in strengths of 12.5 mg, 25 mg and 37.5 mg. The company said its product, a generic version of Paxil CR extended-release tablets (12.5 mg, 25 mg and 37.
The Supreme Court of Canada has rejected an appeal by Sobeys Inc. to permit British Columbia consumers to collect rewards points on pharmacy purchases.
Blistex Inc. has purchased the TUCKS brand of over-the-counter rectal medications from Johnson & Johnson Consumer Inc. Financial terms of the agreement weren’t disclosed. Blistex said Monday that the deal includes the TUCKS businesses in North America as well as international trademark rights.
Walgreens plans to participate in the U.S. Precision Medicine Initiative Cohort Program, part of a sweeping federal medical research initiative to help develop individualized care based on a person’s genomic makeup.
Medication reconciliation programs can help patients avoid hospital readmission and, in turn, unnecessary health care costs, according to a study from the CVS Health Research Institute.
Galderma Laboratories L.P. has gained Food and Drug Administration approval for Differin Gel, an over-the-counter treatment for acne. Galderma said Friday that Differin Gel (adapalene gel 0.
Marc Poulin has left his posts as president and chief executive officer of Sobeys Inc. and the Canadian food and drug retailer’s parent company, Empire Co. His sudden departure, announced by Empire’s board on Friday, comes just over a week after Empire reported a $2.13 billion net loss for its 2016
During the Walgreens Boots Alliance’s conference call this week on its third-quarter results, co-COO Alex Gourlay told analysts that WBA will address Valeant Pharmaceuticals International’s concerns about its distribution arrangement with the company.
Scott’s Liquid Gold-Inc. has acquired of the Prell, Denorex and Zincon brands of hair and scalp care products from Ultimark Products Inc. Scott’s said Thursday that it purchased the three consumer brands for approximately $9.1 million, subject to adjustment.
Fred’s Pharmacy reports that it’s gaining traction with its preventive health care services. Fred’s said Thursday that it provided more than 100,000 preventive screening touchpoints during its 2016 first quarter.
CVS Pharmacy has set up a mobile pharmacy in Elkview, W.Va., to serve residents impacted by the severe flooding that devastated the area late last month.
Stefano Pessina said Walgreens Boots Alliance remains in the ballpark in terms of likely store divestitures that the Federal Trade Commission will require for WBA to finalize its deal to acquire Rite Aid Corp. “We still believe that our initial estimate is correct.
Mylan N.V. has launched fenofibrate tablets 40 mg and 120 mg, a cholesterol-lowering drug, in the United States. Mylan said Wednesday that its fenofibrate product is a generic version of Fenoglide tablets from Santarus.
Walgreens Boots Alliance (WBA) saw sales and adjusted net earnings rise in its fiscal 2016 third quarter, with adjusted earnings per share exceeding Wall Street’s consensus forecast. WBA said Wednesday that its pending acquisition of Rite Aid Corp.
